Inovio Pharma drops on stock offering plans

By Reuters News

** Inovio Pharmaceuticals' INO.O shares down 22.1% to $1.13 in extended trading as it seeks equity raise

** Biotech firm announces stock offering without disclosing deal size

** Jefferies and Piper Sandler joint bookrunners

** INO shares more than tripled to close at $1.89 on Mon after the US FDA approved co's rare throat disease treatment, branded as Voceryq

** Plymouth Meeting, Pennsylvania-based INO has ~110.2 mln shares outstanding as of Sept 30, per the prospectus

** INO shares finished down 10.5% at $1.45 on Thurs

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.